Tevogen (TVGN) adds 100M to equity plan, OKs written consent
Rhea-AI Filing Summary
Tevogen Inc. (TVGN) reported results of its August 24, 2026 annual stockholder meeting and related governance changes. Stockholders approved an amendment to the Tevogen Inc. 2024 Omnibus Incentive Plan, increasing the shares of common stock available for issuance under the plan by 100,000,000.
Stockholders also approved a Certificate of Amendment to the Certificate of Incorporation, filed on August 26, 2026, to permit stockholders to act by written consent in lieu of a meeting, effective upon filing. As of the July 23, 2026 record date, there were 6,416,540 shares outstanding, with 5,956,141 shares represented at the meeting, constituting a quorum. Two Class II directors were elected and KPMG LLP was ratified as independent auditor for 2026.
Positive
- None.
Negative
- None.
Filing Explained
The approved amendment adds 100,000,000 shares to the 2024 plan’s available issuance capacity; the filing does not report that these shares have been issued. If issued, they would increase the total share count and reduce existing holders’ percentage ownership absent offsetting changes.
8-K Event Classification
4 items: 5.02, 5.03, 5.07, 9.01
4 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 5.03
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
2024 Plan share increase: 100,000,000 shares of Common Stock
Shares outstanding: 6,416,540 shares
Shares represented at meeting: 5,956,141 shares
+5 more
8 metrics
2024 Plan share increase
100,000,000 shares of Common Stock
Additional shares available for issuance under the Tevogen Inc. 2024 Omnibus Incentive Plan
Shares outstanding
6,416,540 shares
Common Stock issued, outstanding and entitled to vote as of July 23, 2026 record date
Shares represented at meeting
5,956,141 shares
Common Stock present in person or by proxy at the annual meeting, constituting a quorum
Election votes for Dr. Keow Lin Goh
5,397,703 votes for; 22,265 against; 2,653 abstentions; 533,520 broker non-votes
Class II director election at the annual meeting
Election votes for Victor Sordillo
5,395,249 votes for; 24,751 against; 2,621 abstentions; 533,520 broker non-votes
Class II director election at the annual meeting
Auditor ratification votes
5,939,035 for; 14,666 against; 2,440 abstentions
Ratification of KPMG LLP as independent registered public accounting firm for 2026
Plan Amendment votes
5,322,668 for; 98,744 against; 1,209 abstentions; 533,520 broker non-votes
Approval of 2024 Omnibus Incentive Plan Amendment
Charter Amendment votes
5,382,051 for; 38,005 against; 2,565 abstentions; 533,520 broker non-votes
Approval to permit stockholders to act by written consent in lieu of a meeting
Key Terms
2024 Omnibus Incentive Plan, Certificate of Amendment, written consent in lieu of a meeting, broker non-votes, +1 more
5 terms
2024 Omnibus Incentive Plan financial
"approved an amendment to the Tevogen Inc. 2024 Omnibus Incentive Plan"
Certificate of Amendment regulatory
"the Company filed a Certificate of Amendment to its Certificate of Incorporation"
A certificate of amendment is an official filing that updates a company’s founding documents—its legal “rulebook” that sets share structure, voting rules, name and basic purpose. Think of it like changing the blueprint of a building: small changes are paperwork, big ones can alter who owns how much and who controls decisions. Investors watch these filings because they can affect share counts, voting power, dilution and company value.
written consent in lieu of a meeting regulatory
"to permit stockholders to act by written consent in lieu of a meeting"
A written consent in lieu of a meeting is a signed document by a company’s board members or shareholders that approves a specific corporate action without convening a formal meeting. Like signing a group text instead of gathering in person, it speeds decisions and lowers costs, but it also concentrates voting power and limits public debate, so investors watch it for how quickly actions occur and how transparently votes are recorded.
broker non-votes financial
"2,653 | | 533,520 broker non-votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm financial
"ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
FAQ
What key equity plan change did Tevogen Inc. (TVGN) stockholders approve?
Stockholders approved an amendment to the Tevogen Inc. 2024 Omnibus Incentive Plan to increase the number of shares of common stock available for issuance by 100,000,000, as described in the company’s proxy materials and formalized in Amendment No. 2 to the plan.
What governance change to Tevogen Inc. (TVGN) charter was approved?
Stockholders approved a Certificate of Amendment to the Certificate of Incorporation permitting stockholders to act by written consent in lieu of a meeting. The amendment was filed with the Delaware Secretary of State on August 26, 2026 and became effective upon filing.
What quorum was present at Tevogen Inc.’s 2026 annual meeting?
Holders of 5,956,141 shares of Tevogen Inc. common stock were represented in person or by proxy at the annual meeting, constituting a quorum of the 6,416,540 shares outstanding as of the July 23, 2026 record date.
Who was elected to the Tevogen Inc. (TVGN) board at the 2026 annual meeting?
Stockholders elected Dr. Keow Lin Goh and Victor Sordillo as Class II directors, each to serve a three-year term and until a successor is duly elected and qualified or until earlier death, disqualification, resignation, or removal.
Which auditing firm did Tevogen Inc. (TVGN) stockholders ratify for 2026?
Stockholders ratified KPMG LLP as Tevogen Inc.’s independent registered public accounting firm for the fiscal year ending December 31, 2026, with 5,939,035 votes for, 14,666 votes against, and 2,440 abstentions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
